Legal Representation
Attorney
Michael T. Smith
USPTO Deadlines
Next Deadline
1534 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-10)
Due Date
October 10, 2029
Grace Period Ends
April 10, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 10, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 6, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 5, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 10, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 8, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 26, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 26, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 26, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 26, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 2, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 7, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 7, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 18, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 2, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 29, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 27, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 27, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 9, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 9, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 9, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 18, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 18, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 2, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 2, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 2, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 21, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 20, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 4, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| May 4, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 4, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 4, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 4, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 4, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| May 4, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 16, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Proteins for detecting antibodies for scientific or research use; monoclonal antibodies for industrial use; monoclonal antibody reagents for scientific or research use; immunological antibodies, being biochemical for scientific or research use; tagged antibodies being biochemicals for scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; monoclonal antibodies for scientific use; monoclonal antibodies for research purposes; reagents for use in industry for development of monoclonal antibodies; tagged antibodies being biochemicals for scientific or research laboratory use; reagents for use in antibody discovery for scientific or research use
First Use Anywhere:
20230400
First Use in Commerce:
20230400
Class 040
Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; Custom manufacture of nutraceuticals; Custom manufacture of vitamins
First Use Anywhere:
20230400
First Use in Commerce:
20230400
Class 042
Scientific research; research and development services in the field of antibodies; scientific research services and new product development in the field of monoclonal antibodies; product development for others; pharmaceutical research and development services; scientific research and development; Research in the field of pharmaceuticals; research and development of new products; pharmaceutical drug development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies
First Use Anywhere:
20230400
First Use in Commerce:
20230400
Additional Information
Design Mark
The mark consists of the word WuXiLiAb in stylized font with an arched line swooping from the front of the letter "u" and ending at the dot over the second letter "i" with a leaf and circle shape connected to a vertical line creating the letter "b" at the end.
Classification
International Classes
001
040
042